Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23608992 | 0.74 | — | — | |
| SCHEMBL3158483 | 0.73 | — | — | |
| SCHEMBL22055516 | 0.70 | MAPK1 (0.49) | RAB9AMAPTSMN1; SMN2NPC1CASP3 | |
| SCHEMBL14606380 | 0.69 | — | — | |
| SCHEMBL20151074 | 0.64 | GAA (0.36) | RAB9AMAPTSMN1; SMN2NPC1CASP3 | |
| SCHEMBL13514040 | 0.64 | — | — | |
| SCHEMBL19300886 | 0.64 | TDP1 (0.33) | RAB9AMAPTSMN1; SMN2NPC1LMNA | |
| SCHEMBL18867349 | 0.63 | HPGD (0.54) | RAB9AMAPTSMN1; SMN2NPC1LMNA | |
| SCHEMBL8946056 | 0.60 | — | — | |
| SCHEMBL15133699 | 0.60 | RAB9A (0.38) | RAB9AMAPTSMN1; SMN2NPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | TST, SELENOI, SELE | RAB9A 3400/4885MAPT 2243/4885SMN1; SMN2 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.